eFT226,sotorasib,Abemaciclib
effector therapeutics,amgen,eli lilly
['breast', 'zotatifin', 'bcsm']
zotatifin triplet shows promising activity, low toxicity in heavily pretreated er+ breast cancer #asco23 #bcsm
SVP, Content @MJHLifeSciences. Focused on creating innovative, expert-driven content @OncLive @MedEconomics @AJMC_Journal @Pharmacy_Times @MDMagazine plus more